Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-008616

CHIEF OPERATING OFFICER gave up 577 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 1,964 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2025-03-16 Option exercise +1,964 78,530 D
Tessari Eben CHIEF OPERATING OFFICER 2025-03-16 Shares withheld for taxes −577 $22.61 $13,046 77,953 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2025-03-16 Option exercise · Restricted Share Unit −1,964 0 D
Loading xslF345X05/form4-03192025_090333.xml…